Terms: = Breast cancer AND IDH1, IDP, 3417, ENSG00000138413, IDH, PICD, O75874 AND Prognosis
26 results:
1. Correlation of idh1 gene expression error in breast tumor biopsy in patients with invasive ductal carcinoma.
Rostami B; Kahrizi S; Ghorbani Yekta B; Ghadyani R; Keramatinia A; Hoseini SJ; Karima S; Nikzamir AR; Mansouri N; Chen M; Movafagh A
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):242-247. PubMed ID: 38678597
[TBL] [Abstract] [Full Text] [Related]
2. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway.
Ci M; Zhao G; Li C; Liu R; Hu X; Pan J; Shen Y; Zhang G; Li Y; Zhang L; Liang P; Cui H
Cell Death Dis; 2024 Mar; 15(3):179. PubMed ID: 38429268
[TBL] [Abstract] [Full Text] [Related]
3. MRPS23 is a novel prognostic biomarker and promotes glioma progression.
Wang Q; Chen G; Liu L; Peng X; Yang X; Yang L; Li C
Aging (Albany NY); 2024 Jan; 16(3):2457-2474. PubMed ID: 38301044
[TBL] [Abstract] [Full Text] [Related]
4. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
5. BCL2A1 is associated with tumor-associated macrophages and unfavorable prognosis in human gliomas.
Gao L; Ye Z; Peng S; Lei P; Song P; Li Z; Zhou L; Hua Q; Cheng L; Wei H; Liu J; Cai Q
Aging (Albany NY); 2023 Oct; 15(20):11611-11638. PubMed ID: 37889551
[TBL] [Abstract] [Full Text] [Related]
6. Low Expression of A3C and PLP2 Indicating a Favorable prognosis in Human Gliomas.
Jin JS; Tsai YL; Chang YC; Tsai WC
Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):71-79. PubMed ID: 37715423
[TBL] [Abstract] [Full Text] [Related]
7. Macroscopic and multiple metastases in sentinel lymph node biopsy are respectively associated with poor prognosis in early oral cancer.
Kondo T; Tsukahara K; Kawakita D; Yoshimoto S; Miura K; Sugasawa M; Chikamatsu K; Matsuzuka T; Oze I; Kitamura M; Murakami Y; Otozai S; Shinozaki T; Ohba S; Araki K; Mizumachi T; Sato D; Wakisaka N; Hirakawa H; Hasegawa Y
Int J Clin Oncol; 2023 Apr; 28(4):512-520. PubMed ID: 36795281
[TBL] [Abstract] [Full Text] [Related]
8. Molecular Spectra and Frequency Patterns of Somatic Mutations in Arab Women with breast cancer.
Al-Shamsi HO; Abu-Gheida I; Abdulsamad AS; AlAwadhi A; Alrawi S; Musallam KM; Arun B; Ibrahim NK
Oncologist; 2021 Nov; 26(11):e2086-e2089. PubMed ID: 34327780
[TBL] [Abstract] [Full Text] [Related]
9. Poor prognosis of male triple-positive breast cancer patients: a propensity score matched SEER analysis and molecular portraits.
Wang B; Wang H; Zhao A; Zhang M; Yang J
BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
[TBL] [Abstract] [Full Text] [Related]
10. Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma.
Boerner T; Drill E; Pak LM; Nguyen B; Sigel CS; Doussot A; Shin P; Goldman DA; Gonen M; Allen PJ; Balachandran VP; Cercek A; Harding J; Solit DB; Schultz N; Kundra R; Walch H; D'Angelica MI; DeMatteo RP; Drebin J; Kemeny NE; Kingham TP; Simpson AL; Hechtman JF; Vakiani E; Lowery MA; Ijzermans JNM; Buettner S; Koerkamp BG; Doukas M; Chandwani R; Jarnagin WR
Hepatology; 2021 Sep; 74(3):1429-1444. PubMed ID: 33765338
[TBL] [Abstract] [Full Text] [Related]
11. Isoforms of idh in breast carcinoma: idh2 as a potent prognostic factor associated with proliferation in estrogen-receptor positive cases.
Minemura H; Takagi K; Sato A; Yamaguchi M; Hayashi C; Miki Y; Harada-Shoji N; Miyashita M; Sasano H; Suzuki T
Breast Cancer; 2021 Jul; 28(4):915-926. PubMed ID: 33713004
[TBL] [Abstract] [Full Text] [Related]
12. Differential expression of the BCAT isoforms between breast cancer subtypes.
Shafei MA; Flemban A; Daly C; Kendrick P; White P; Dean S; Qualtrough D; Conway ME
Breast Cancer; 2021 May; 28(3):592-607. PubMed ID: 33367952
[TBL] [Abstract] [Full Text] [Related]
13. Identifying Genomic Alterations in Patients With Stage IV breast cancer Using MammaSeq: An International Collaborative Study.
Shah OS; Soran A; Sahin M; Knapick BA; Ugras S; Celik E; Lucas PC; Lee AV
Clin Breast Cancer; 2021 Jun; 21(3):210-217. PubMed ID: 33191115
[TBL] [Abstract] [Full Text] [Related]
14. RIPK3 is a novel prognostic marker for lower grade glioma and further enriches idh mutational status subgrouping.
Vergara GA; Eugenio GC; Malheiros SMF; Victor EDS; Weinlich R
J Neurooncol; 2020 May; 147(3):587-594. PubMed ID: 32222932
[TBL] [Abstract] [Full Text] [Related]
15. 2-Hydroxyglutarate in cancer Cells.
Ježek P
Antioxid Redox Signal; 2020 Nov; 33(13):903-926. PubMed ID: 31847543
[No Abstract] [Full Text] [Related]
16. Anti-Apoptotic and Anti-Oxidant Proteins in Glioblastomas: Immunohistochemical Expression of Beclin and DJ-1 and Its Correlation with prognosis.
Guadagno E; Borrelli G; Pignatiello S; Donato A; Presta I; Arcidiacono B; Malara N; Solari D; Somma T; Cappabianca P; Donato G; Del Basso De Caro M
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31434323
[TBL] [Abstract] [Full Text] [Related]
17. Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases.
Alsadoun N; MacGrogan G; Truntzer C; Lacroix-Triki M; Bedgedjian I; Koeb MH; El Alam E; Medioni D; Parent M; Wuithier P; Robert I; Boidot R; Arnould L
Mod Pathol; 2018 Sep; 31(9):1367-1380. PubMed ID: 29785016
[TBL] [Abstract] [Full Text] [Related]
18. Isocitrate dehydrogenase 1-snail axis dysfunction significantly correlates with breast cancer prognosis and regulates cell invasion ability.
Liu WS; Chan SH; Chang HT; Li GC; Tu YT; Tseng HH; Fu TY; Chang HY; Liou HH; Ger LP; Tsai KW
Breast Cancer Res; 2018 Apr; 20(1):25. PubMed ID: 29661250
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive molecular biomarker identification in breast cancer brain metastases.
Schulten HJ; Bangash M; Karim S; Dallol A; Hussein D; Merdad A; Al-Thoubaity FK; Al-Maghrabi J; Jamal A; Al-Ghamdi F; Choudhry H; Baeesa SS; Chaudhary AG; Al-Qahtani MH
J Transl Med; 2017 Dec; 15(1):269. PubMed ID: 29287594
[TBL] [Abstract] [Full Text] [Related]
20. SIRT3 Silencing Sensitizes breast cancer Cells to Cytotoxic Treatments Through an Increment in ROS Production.
Torrens-Mas M; Pons DG; Sastre-Serra J; Oliver J; Roca P
J Cell Biochem; 2017 Feb; 118(2):397-406. PubMed ID: 27420645
[TBL] [Abstract] [Full Text] [Related]
[Next]